Sisram Medical Ltd. to Hold First Half 2022 Financial Results Conference Call on August 22 at 8:30 a.m. ET
28.06.22
Sisram Medical’s associate company Tianjin JuveStar released Phase IIb result of lipolysis injection, reduction of submental fat by 15% through one treatment
10.05.22
LMNT, Sisram Medical’s Home-use Brand, is Officially Launching in China
25.03.22
Alma, a Sisram Medical Company, Announces the Launch of Alma TED™ and the Company’s Professional Skincare Line for the U.S. Market
16.03.22
Sisram Medical Ltd Announces 2021 Record Annual Results. Strong Performance Led by Synergistic Development of Four Main Business Lines Under One Ecosystem.
09.01.22
Sisram Medical has Increased the Shares by the Controlling Shareholder Fosun Pharma, Demonstrating Shareholder’s Strong Confidence
14.09.21
Alma Hybrid Platform by Alma, a Sisram Medical company, Wins 2021 Gold Award for Industrial and Life Science Medical/Scientific Machinery Design
22.08.21
Sisram Medical Ltd, Announces Its Interim Results for the First Half of 2021 Demonstrating an Impressive Performance Led by Global Business Expansion and R&D Breakthroughs
15.07.21
Sisram Medical (1696.HK) and Fosun Industrial Enter into a Sublicense Agreement for the Commercialization of DaxibotulinumtoxinA (RT002) Injectable
